Funding

Germany Skleo Health Secures €3Million In Seed Round

Jul 10, 2025 | By Kailee Rainse

German healthtech startup Skleo Health has raised €3 million in seed funding to expand its network of fast, accessible eye screenings across the country.

SUMMARY

  • German healthtech startup Skleo Health has raised €3 million in seed funding to expand its network of fast, accessible eye screenings across the country.

In Germany, 9.7 million people suffer from preventable eye conditions like glaucoma and diabetic eye disease. Yet, long wait times—averaging 56 days—mean 31% of patients receive treatment too late.

Skleo Health aims to fix this by offering quick, six-minute screenings at pharmacies, opticians, retail stores, and workplaces. Each screening is first analyzed by certified AI, then reviewed by an eye specialist to ensure accuracy.

Read Also - Wrisk Funding News- London-based Wrisk Secures €13.9 Million Funding

Supported by experts from Charité Berlin, UCL London and Yale University, Skleo’s model helps detect eye diseases early, prioritizes patients who need care, and eases pressure on the healthcare system.

Dr. Steffen E. Künzel, Co-founder of Skleo Health, comments: Every day in the clinic I witnessed the profound impact of late-stage diagnosis, where treatment options are often limited and the outcomes are uncertain. We founded Skleo Health to fundamentally change this reality. By bringing certified, medically validated screenings into everyday life, we are replacing reactive treatment with proactive prevention.

This funding allows us to build a new standard of care where early detection is the norm, not the exception, ensuring we can save the sight of millions.

The funding round was led by Sanoptis, Europe’s top ophthalmology services provider, with participation from Antler, Europe’s most active early-stage VC, and several prominent angel investors.

Dr. Volker Wendel Founder and CEO of Sanoptis comments: At Sanoptis, our mission is to make excellent eye care accessible to everyone - and we see Skleo Health as a key driver in transforming how preventive care is delivered across Europe. Skleo's approach, which combines medical expertise with cutting-edge AI and an easily accessible screening infrastructure is shaping the future of eye care. By identifying diseases earlier and being closer to the patient, they are tackling one of the biggest challenges in ophthalmology today: late diagnosis.

We are proud to bring our clinical network and expertise to this partnership, and confident that Skleo’s model represents a new era in proactive, patient-centred eye care.

Skleo Health’s founding team came together during an Antler founder residency in Berlin in late 2023. Together, they bring strong medical and business expertise to the company.

Alan Poensgen, Partner at Antler, comments: Skleo Health will radically improve eyecare in Germany and across Europe. The precision and speed with which Skleo Health has built an offering that addresses the exact problems facing patients and doctors only comes from firsthand experience.

The founding team combines the medical expertise of Steffen with the technical and business experience of Fabien and Alex. They know their market, they have built a solution, and they are now executing and scaling to deliver their vision. It’s been a pleasure working with the founders from day zer,o and I have every confidence in their future success.

Since launching in March 2024, Skleo Health has expanded to 50 major cities in Germany, screening over 11,000 people and identifying more than 3,000 with significant eye health issues.

The new funding will help grow its partner network to reach 30,000 screenings per month. Skleo also plans to build an open, nationwide platform that connects patients with specialist eye doctors.

A strategic partnership with lead investor Sanoptis is speeding up this expansion, while part of the funding will go toward enhancing Skleo’s AI-powered diagnostic tools.

About Skleo

Founded in 2024, Skleo Health is a German health-tech company working to prevent blindness through accessible, early eye screenings. Its platform enables opticians, pharmacies, retailers and workplaces to offer fast screenings powered by AI and verified by licensed eye doctors. Skleo also connects patients directly with specialists, making the path from detection to treatment simple and effective.

Recommended Stories for You